Paget’s disease of bone
Osteitis deformans is a chronic progressive bone disease characterized by the coexistence of local bone tissue osteoclasts and osteogenesis, bone absorption and reconstruction, osteoporosis and calcification. The disease is a chronic focal bone remodeling abnormality of unknown cause. Initially, bone absorption increases at the lesion site, followed by an increase in compensatory new bone formation, which causes the woven bone and lamellar bone at the lesion site to be inlaid, leading to disordered bone structure, bone enlargement and thickening, bone fragility, and increased intraosseous blood vessels at the lesion site. Clinical manifestations include bone pain, bone deformity and fracture. The disease does not directly invade the joints, but bone deformity can cause secondary joint lesions.
Related Drugs
Compound Amino Acid Injection (18AA-Ⅱ)
Indication: For patients who cannot take nutrition orally or enterally, or whose nutrition cannot meet their needs, this product can be infused intravenously to meet the body's needs for protein synthesis.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (18AA-Ⅱ)
Indication: For patients who cannot take nutrition orally or enterally, or whose nutrition cannot meet their needs, this product can be infused intravenously to meet the body's needs for protein synthesis.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (18AA-Ⅰ)
Indication: For patients who cannot take nutrition orally or enterally, or whose nutrition cannot meet their needs, this product can be infused intravenously to meet the body's needs for protein synthesis.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Compound Lysine Granules
Indication: Used to prevent and treat lack of appetite and malnutrition in children caused by lysine deficiency and to supplement lysine, vitamins and calcium.
Manufacturer:
Guangxi Nanning Yongjiang Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (17AA)
Indication: For patients who cannot take nutrition orally or enterally, or whose nutrition cannot meet their needs, this product can be infused intravenously to meet the body's needs for protein synthesis.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (9AA)
Indication: For patients who cannot take nutrition orally or enterally, or whose nutrition cannot meet their needs, this product can be infused intravenously to meet the body's needs for protein synthesis.
Manufacturer:
Cisen Pharmaceutical Co., Ltd.
Compound Amino Acid Injection (9AA)
Indication: For parenteral support in patients with acute and chronic renal insufficiency; severe renal failure caused by major surgery, trauma or sepsis, as well as acute and chronic renal failure.
Manufacturer:
Shaanxi Jinyu Pharmaceutical Co., Ltd.